109 related articles for article (PubMed ID: 208492)
21. Mason-Pfizer virus characterization: a similar virus in a human amniotic cell line.
Parks WP; Gilden RV; Bykovsky AF; Miller GG; Zhdanov VM; Soloviev VD; Scolnick EM
J Virol; 1973 Dec; 12(6):1540-7. PubMed ID: 4128382
[TBL] [Abstract][Full Text] [Related]
22. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
Rizvi TA; Schmidt RD; Lew KA; Keeling ME
Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
[TBL] [Abstract][Full Text] [Related]
23. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.
Gottwein E; Bodem J; Müller B; Schmechel A; Zentgraf H; Kräusslich HG
J Virol; 2003 Sep; 77(17):9474-85. PubMed ID: 12915562
[TBL] [Abstract][Full Text] [Related]
24. Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus.
Chatterjee S; Bradac J; Hunter E
J Virol; 1981 May; 38(2):770-6. PubMed ID: 7241666
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of SV40 DNA replication by Rous sarcoma virus LTR enhancer.
Binninger D; Ferdinand FJ; Rübsamen-Waigmann H
Arch Virol; 1989; 107(3-4):291-9. PubMed ID: 2554858
[TBL] [Abstract][Full Text] [Related]
26. Correlation of collagen synthesis and procollagen messenger RNA levels with transformation in rat embryo fibroblasts.
Sandmeyer S; Smith R; Kiehn D; Bornstein P
Cancer Res; 1981 Mar; 41(3):830-8. PubMed ID: 6257385
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay for the major structural protein of Mason-Pfizer monkey virus: Attempts to detect the presence of antigen or antibody in humans.
Charman HP; Rahman R; White MH; Kim N; Gilden RV
Int J Cancer; 1977 Apr; 19(4):498-504. PubMed ID: 403148
[TBL] [Abstract][Full Text] [Related]
28. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes.
Tarone G; Cirillo D; Giancotti FG; Comoglio PM; Marchisio PC
Exp Cell Res; 1985 Jul; 159(1):141-57. PubMed ID: 2411576
[TBL] [Abstract][Full Text] [Related]
29. Characterization of infection and replication of Mason-Pfizer monkey virus in human cell cultures.
Fine DL; Clarke GC; Arthur LO
J Gen Virol; 1979 Aug; 44(2):457-69. PubMed ID: 118235
[TBL] [Abstract][Full Text] [Related]
30. Immunofluorescent and electron microscopic studies of cultured human cells successively transformed by Rous sarcoma virus and simian virus 40.
Egusa K; Kuwata T; Oda T
Acta Med Okayama; 1973 Dec; 27(5):165-75. PubMed ID: 4360762
[No Abstract] [Full Text] [Related]
31. Some characteristics of a retrovirus isolated from transformed bovine cells.
York DF; Williamson A; Barnard BJ; Verwoerd DW
Virology; 1989 Aug; 171(2):394-400. PubMed ID: 2763459
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of antigenic cross-reactivity between simian sarcoma virus (SSV) and mason-pfizer monkey virus (MPMV): brief report.
Micheel B
Arch Virol; 1981; 69(2):149-53. PubMed ID: 6171238
[No Abstract] [Full Text] [Related]
33. Rous sarcoma virus precursor protein pr 76 is processed in avian sarcoma virus-transformed mammalian cells after fusion-injection of viral protein p 15.
von der Helm K; Kempeni J; Wille W; Willecke K
Virology; 1980 Oct; 106(2):310-6. PubMed ID: 6254253
[No Abstract] [Full Text] [Related]
34. [Molecular biology criteria for functioning of the genome of Rous sarcoma virus in transformed rat XC cells].
Kiselev FL; Galetskiĭ SA; Mazurenko NN; Asanova AA; Zborovskaia IB
Mol Biol (Mosk); 1982; 16(1):66-76. PubMed ID: 6280033
[TBL] [Abstract][Full Text] [Related]
35. Differential response to cytochalasin B among cells transformed by DNA and RNA tumor viruses.
O'Neill FJ; Miller TH; Hoen J; Stradley B; Devlahovich V
J Natl Cancer Inst; 1975 Oct; 55(4):951-5. PubMed ID: 171432
[TBL] [Abstract][Full Text] [Related]
36. RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.
Hull S; Boris-Lawrie K
J Virol; 2002 Oct; 76(20):10211-8. PubMed ID: 12239296
[TBL] [Abstract][Full Text] [Related]
37. Mixed-culture cytopathogenicity between KC and XC oncornavirus indicator lines and "virus-free" human choriocarcinoma cells.
Rand KH; Reed B; Broseus I; Hampar B; Gilden R; Long C
J Natl Cancer Inst; 1976 Mar; 56(3):509-12. PubMed ID: 176395
[TBL] [Abstract][Full Text] [Related]
38. TUMOUR-VIRUSES AND VIRUS-TUMOURS.
ANDREWS C
Br Med J; 1964 Mar; 1(5384):653-8. PubMed ID: 14096457
[No Abstract] [Full Text] [Related]
39. Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey.
Nowinski RC; Edynak E; Sarkar NH
Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1608-12. PubMed ID: 4997759
[TBL] [Abstract][Full Text] [Related]
40. A G-C-rich palindromic structural motif and a stretch of single-stranded purines are required for optimal packaging of Mason-Pfizer monkey virus (MPMV) genomic RNA.
Jaballah SA; Aktar SJ; Ali J; Phillip PS; Al Dhaheri NS; Jabeen A; Rizvi TA
J Mol Biol; 2010 Sep; 401(5):996-1014. PubMed ID: 20600114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
